Ziftomenib Combined with Intensive Induction (7+3) in Newly Diagnosed NPM1-m or KMT2A-r Acute Myeloid Leukemia: Interim Phase 1a Results from KOMET-007
Amer M. Zeidan,Eunice S. Wang,Ghayas C. Issa,Harry Erba, Jessica Kaplan Altman,Suresh Kumar Balasubramanian,Stephen Anthony Strickland,Gail J. Roboz,Gary J. Schiller,Christine M. McMahon,Neil D. Palmisiano,Yazan F. Madanat,Marcello Rotta,Kalyan Nadiminti,Helen Wei, Marcie Riches,Daniel Corum,Mollie Leoni,Stephen Dale,Amir T. Fathi Blood（2024）
AI 理解论文
溯源树
样例
